Ascelia Pharma AB (OSTO:ACE) Accounts Payable & Accrued Expense : kr1.09 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Ascelia Pharma AB Accounts Payable & Accrued Expense?

Ascelia Pharma AB's quarterly accounts payable & accrued expense declined from Sep. 2023 (kr4.62 Mil) to Dec. 2023 (kr1.53 Mil) and declined from Dec. 2023 (kr1.53 Mil) to Mar. 2024 (kr1.09 Mil).

Ascelia Pharma AB's annual accounts payable & accrued expense increased from Dec. 2021 (kr6.15 Mil) to Dec. 2022 (kr15.88 Mil) but then declined from Dec. 2022 (kr15.88 Mil) to Dec. 2023 (kr1.53 Mil).

Ascelia Pharma AB Accounts Payable & Accrued Expense Historical Data

The historical data trend for Ascelia Pharma AB's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascelia Pharma AB Accounts Payable & Accrued Expense Chart

Ascelia Pharma AB Annual Data

Trend

Jun17

Jun18

Jun19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

4.27

3.88

6.15

15.88

1.53

Ascelia Pharma AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															8.10	6.50	4.62	1.53	1.09

Ascelia Pharma AB Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Ascelia Pharma AB (OSTO:ACE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascelia Pharma AB (OSTO:ACE) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

7ZA:Germany

Address

Hyllie Boulevard 34, Malmo, SWE, SE-215 32

Website

https://www.ascelia.com

Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo, Sweden, focused on the development of novel drugs to improve the life expectancy and quality of life for people living with cancer. The company is focused on two clinical-stage product candidates under development: Mangoral and Oncoral.

Ascelia Pharma AB (OSTO:ACE) Headlines

No Headlines